SPIRIVA caps inh 18 mcg 30 pce

7680558550085 CH-55855 R03BB04 03.04.3.
SPIRIVA caps inh 18 mcg 30 pce
SPIRIVA caps inh 18 mcg 30 pce
1 / 2
google

Details

Product number
5585501
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
tiotropium 18 µg ut tiotropii bromidum monohydricum, lactosum monohydricum pro capsula.

Articles (1)

Spiriva 18 mcg, Kapseln zur Inhalation
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/07/2021
Professional SmPC
Français
07/07/2021
Professional SmPC
Italien
07/07/2021
Patient information leaflet
Allemand
04/02/2021
Patient information leaflet
Français
04/02/2021
Patient information leaflet
Italien
04/02/2021

Detailed composition

Substance Quantity Type Category
(N/A)
18.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 49.00
Specialties list
Yes
Generic
No
SL addition date: 01/04/2003

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
55855
Drug name
Spiriva, Kapseln zur Inhalation
Galenic form
KAHI
ATC Code
R03BB04
Authorization status
Z
Dispensation category
B
First authorization
16/12/2002
Authorization expiration date
31/12/9999
IT number
03.04.3.
Domain
Human medicine
Field of application
Dauerbehandlung COPD

Packaging details

Description (FR)
SPIRIVA caps inh 18 mcg 30 pce
Description (DE)
SPIRIVA Inh Kaps 18 mcg 30 Stk
Market launch
16/12/2002
Narcotic (BTM)
No

Other packaging sizes

SPIRIVA caps inh 18 mcg 90 pce
90 KAP
View